Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,524
Sort by:
North America Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025
US$ 1,500.00
The North America Tumor Ablation Market would witness market growth of 9.4% CAGR during the forecast period (2019-2025). Tumor ablation treatment is an excellent option over many other conventional tr...
February 2020
86 pages
Arrhythmias - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
87 pages
Viral Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
50 pages
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
558 pages
Alzheimer's Disease - Pipeline Review, H1 2020
US$ 2,500.00
... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
1716 pages
Atrial Fibrillation - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Atrial Fibrillation (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atrial Fibrillation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
127 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
February 2020
178 pages
Diabetic Gastroparesis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
72 pages
Drug Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
221 pages
Duchenne Muscular Dystrophy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
381 pages
Epilepsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
605 pages
Genital Herpes - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
116 pages
Myocardial Ischemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
88 pages
Nasopharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
688 pages
Oral Mucositis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
128 pages
Osteoarthritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
345 pages
Rectal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
202 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
February 2020
167 pages
Candidiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
204 pages
Cough - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
112 pages
Diabetic Nephropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
264 pages
Ocular Hypertension - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
145 pages
African Trypanosomiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The African Trypanosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for African Trypanosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
63 pages
Cat Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Cat Allergy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development ...
February 2020
31 pages
Polycythemia Vera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
129 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
211 pages
Bronchopulmonary Dysplasia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
76 pages
Burns - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
108 pages
Osteosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
726 pages
Pruritus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
207 pages
Blepharitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
61 pages
Encephalomyelitis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Encephalomyelitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
65 pages
Fabry Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
112 pages
Grass Pollen Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
78 pages
Liver Cirrhosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
149 pages
Dementia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
469 pages
Thalassemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
198 pages
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
106 pages
Periodontitis - Pipeline Review, H1 2020
US$ 2,000.00
... And Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Periodontitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
58 pages
Restenosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
62 pages
Seborrhea - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Seborrhea - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Seborrhea (Dermatology), complete with analysis by stage of development ...
February 2020
50 pages
Batten Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
92 pages
Activin Receptor Type 1 - Pipeline Review, H1 2020
US$ 3,500.00
... releases. The Actinic (Solar) Keratosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Actinic (Solar) Keratosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
70 pages
Cryptococcosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cryptococcosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptococcosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
58 pages
Gonorrhea - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gonorrhea (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Gonorrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
114 pages
Myocarditis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
48 pages
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Proliferative Vitreoretinopathy (PVR) (Ophthalmology), complete with analysis by stage of development ...
February 2020
37 pages
Pulmonary Embolism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pulmonary Embolism (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
59 pages
